HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombin generation in children with febrile neutropenia.

AbstractBACKGROUND:
Febrile neutropenia (FN) is a common and serious complication in patients with leukemia. Hemostasis and inflammation are two interrelated systems in response to infection. We aimed to investigate the course of thrombin formation in febrile neutropenia attack of children with acute lymphoblastic leukemia (ALL).
METHODS:
Thrombin generation was monitored in children treated for ALL at diagnosis of febrile neutropenia (FN) (t < sub > 0 < /sub > ), at 48 < sup > th < /sup > hour of FN (t1) and after recovery from neutropenia (t < sub > 2 < /sub > ).
RESULTS:
Twenty-nine patients and 50 healthy children as control were enrolled into the study. Mean endogenous thrombin potential (ETP) and mean peak value of thrombin results at t < sub > 1 < /sub > were significantly higher than at t < sub > 0 < /sub > , t < sub > 2 < /sub > and control groups, respectively. A positive but statistically nonsignificant correlation between ETP values at t < sub > 1 < /sub > and duration of neutropenia was observed.
CONCLUSION:
Although thrombin generation is enhanced both due to chemotherapy or malignancy itself, our results revealed that thrombin formation also increased in neutropenic infection of children with leukemia.
AuthorsAyça Koca Yozgat, İbrahim Eker, Orhan Gürsel, Muhammed Fevzi Kılınçkaya, Abdurrahman Kara, Neşe Yaralı, Namık Yaşar Özbek
JournalThe Turkish journal of pediatrics (Turk J Pediatr) Vol. 63 Issue 2 Pg. 251-256 ( 2021) ISSN: 2791-6421 [Electronic] Turkey
PMID33929114 (Publication Type: Journal Article)
Chemical References
  • Thrombin
Topics
  • Blood Coagulation Tests
  • Child
  • Febrile Neutropenia
  • Humans
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (complications, drug therapy)
  • Thrombin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: